Every patient deserves the best possible treatment. The Early Phase Clinical Trials Center at Amsterdam UMC therefore works closely with innovative companies developing new cancer therapies. Many of our partners, including pharmaceutical companies, have been collaborating with Amsterdam UMC for many years. Other companies and organizations, such as biotech and diagnostics companies or governmental organizations, are also warmly invited to engage with us.
Together, we generate new knowledge to improve the understanding, detection, treatment, and outcomes of cancer for future patients.
Why collaborate with the Early Phase Clinical Trials Center?
- Leading research institute
Amsterdam UMC – Cancer Center Amsterdam is among the top institutes in Europe in terms of the quality of cancer research, measured by the proportion of publications ranking in the top 10% of the field. - Fully integrated infrastructure
Amsterdam UMC offers a fully integrated infrastructure for Phase I and Phase II oncology studies. All supporting medical specialties and facilities are available in-house and closely involved, including intensive care, cardiology, pathology, and biobanking. This multidisciplinary approach enables us to safely conduct complex, high-risk early-phase studies, ensuring that patients are always in expert hands. - Experienced and dedicated teams
The early-phase team at the Amsterdam UMC Early Phase Oncology & Hematology Trial Center is supported by multiple trial offices. In total, more than 100 trial coordinators, research nurses, and data managers work closely together to ensure that all documentation is in order before and during the study. - Quality standards
The Early Phase Clinical Trials Center is certified according to NEN 7510 and ISO 27001. - Efficient collaboration and fast start-up
The Business & Alliance Managers of Amsterdam UMC – Cancer Center Amsterdam provide a clear point of contact and facilitate a rapid study start-up process, in close collaboration with the trial offices.
Brochure for new collaboration partners
Would you like to collaborate with our Early Phase Clinical Trials Center? A brochure has been developed for new partners, providing more detailed information about our research facilities, translational capabilities, and our unique experience with both autologous cell therapy (CAR-T) and advanced imaging studies.
How we work
More information on how the Business & Alliance Managers support collaborations with our Early Phase Clinical Trials Center can be found on this website: